Kuangli Bio-Tech Holdings Co (TPE:6431) EV-to-EBIT: -12.75 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6431 Kuangli Bio-Tech Holdings Co Ltd TPE:6431
56 GF Score
Price NT$20.30
GF Value NT$10.64
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Kuangli Bio-Tech Holdings Co EV-to-EBIT?

Kuangli Bio-Tech Holdings Co TPE:6431 +1.50% 56 EV-to-EBIT is -12.75 as of Aug. 24, 2026. GuruFocus rates TPE:6431 with a GF Score™ of 56/100 and a GF Value™ of NT$10.64 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,567 Consumer Packaged Goods companies, Kuangli Bio-Tech Holdings Co ranks worse than 63816.15% on this metric.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Kuangli Bio-Tech Holdings Co's Enterprise Value is NT$2,195.3 Mil. Kuangli Bio-Tech Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NT$-172.2 Mil. Therefore, Kuangli Bio-Tech Holdings Co's EV-to-EBIT for today is -12.75.

The historical rank and industry rank for Kuangli Bio-Tech Holdings Co's EV-to-EBIT or its related term are showing as below:

TPE:6431' s EV-to-EBIT Range Over the Past 10 Years
Min: -738.52   Med: -11.49   Max: 51.88
Current: -12.75

During the past 13 years, the highest EV-to-EBIT of Kuangli Bio-Tech Holdings Co was 51.88. The lowest was -738.52. And the median was -11.49.

TPE:6431's EV-to-EBIT is ranked worse than
100% of 1567 companies
in the Consumer Packaged Goods industry
Industry Median: 12.17 vs TPE:6431: -12.75

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Kuangli Bio-Tech Holdings Co's Enterprise Value for the quarter that ended in Mar. 2026 was NT$2,507.0 Mil. Kuangli Bio-Tech Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NT$-172.2 Mil. Kuangli Bio-Tech Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -6.87%.


Kuangli Bio-Tech Holdings Co  (TPE:6431) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Kuangli Bio-Tech Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2026 ) =EBIT / Enterprise Value (Q: Mar. 2026 )
=-172.223/2507.0275
=-6.87 %

Kuangli Bio-Tech Holdings Co's Enterprise Value for the quarter that ended in Mar. 2026 was NT$2,507.0 Mil.
Kuangli Bio-Tech Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-172.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kuangli Bio-Tech Holdings Co EV-to-EBIT Related Terms


Kuangli Bio-Tech Holdings Co EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Kuangli Bio-Tech Holdings Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kuangli Bio-Tech Holdings Co EV-to-EBIT Chart

Kuangli Bio-Tech Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.88 -20.86 -13.26 -8.08 -15.61

Kuangli Bio-Tech Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.60 -9.96 -9.05 -15.61 -14.56

TPE:6431 vs PG, CL, KVUE: EV-to-EBIT Comparison

For the Household & Personal Products subindustry, Kuangli Bio-Tech Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kuangli Bio-Tech Holdings Co EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kuangli Bio-Tech Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kuangli Bio-Tech Holdings Co's EV-to-EBIT falls into.


TPE:6431
56GF Score
Kuangli Bio-Tech Holdings Co Ltd TPE:6431
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kuangli Bio-Tech Holdings Co EV-to-EBIT Calculation

Kuangli Bio-Tech Holdings Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2195.347/-172.223
=-12.75

Kuangli Bio-Tech Holdings Co's current Enterprise Value is NT$2,195.3 Mil.
Kuangli Bio-Tech Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-172.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -12.75 mean?
Kuangli Bio-Tech Holdings Co (TPE:6431) has a EV-to-EBIT of -12.75 as of Aug. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. According to the industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #999999 out of 1567 companies in the Consumer Packaged Goods industry.
Is Kuangli Bio-Tech Holdings Co's EV-to-EBIT too high?
Kuangli Bio-Tech Holdings Co's current EV-to-EBIT is -12.75. Based on the distribution chart, Kuangli Bio-Tech Holdings Co ranks #999999 out of 1567 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's EV-to-EBIT compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #999999 out of 1567 companies for EV-to-EBIT. This places Kuangli Bio-Tech Holdings Co in the lower half of its industry. The industry median EV-to-EBIT is 12.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.17, based on 1,567 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kuangli Bio-Tech Holdings Co's current EV-to-EBIT is -12.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$10.64, compared to a current price of NT$20.30 — trading 90.8% above its estimated fair value. The current EV-to-EBIT is -12.75. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current EV-to-EBIT is -12.75 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?

Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued. The current stock price of NT$20.30 is trading 90.8% above its estimated GF Value™ of NT$10.64. GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.

Key valuation signals for TPE:6431:

  • EV-to-EBIT: -12.75
  • GF Value™: NT$10.64 vs. price of NT$20.30 (90.8% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kuangli Bio-Tech Holdings Co Business Description

Address North Sound Road, Suite 102, Cannon Place, George Town, Grand Cayman, CYM
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
56GF Score

Get the complete analysis for TPE:6431

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.30
Price
NT$10.64
GF Value